Haverhill’s new spray dryer, slated to become available in the last quarter of 2027, will expand solvent-based capacity for amorphous solid dispersions.

CARR’s single-use centrifugation platform will support process volumes from milliliters to more than 2,000 liters, according to the companies.

The agreement assigns recombinant human apoA-I purification to Axplora’s site in France, completing the planned manufacturing network.

The equipment will help formulation scientists assess scale-up risks using small quantities of active pharmaceutical ingredients before commercial manufacturing.

The Valladolid expansion will add capacity for steroid and non-steroid active pharmaceutical ingredients, supporting complex sterile formulations and production.

The expanded BARDA deal adds approximately $270 million in procurement through 2031 as the company advances an investigational antibody against another Ebola virus species.

The bioprocessing supplier opened an X-ray irradiation facility, started a second phase of campus construction, and introduced an automated bulk-product aliquoting platform.

The new Shaoxing site adds 250 cubic meters of reactor capacity, with room for future expansion to more than 400 cubic meters.